Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Other, SGLT2i Oct 15 | 2021Forxiga Pediatric Indication and Generic Sitagliptin Receive Positive CHMP OpinionsPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other Oct 14 | 2021G&L Bs-glargine Completes Ph3; Adocia’s BC Lispro Cleared for Pivotal Ph3 in China; Dario Signs National Digital Behavioral Health ContractPurchase Blast
$599
Posted in: Basal Insulin, Glucose Monitoring, Insulin Delivery Oct 13 | 2021Dexcom Launches Garmin Connect IQ Apps for Dexcom G6; Dexcom Expands TIR Educational Campaign in UKPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery, SGLT2i Oct 12 | 2021vTv Therapeutics Announces Positive Results from TTP399 Mechanistic Trial; Non-Invasive CGM From Innovation Zed AdvancesPurchase Blast
$599
Posted in: Bolus Insulin, DPP-IVi, GLP-1RA, Other, SGLT2i Oct 11 | 2021Jardiance HFpEF Indication Filed in EU; Generic Sitagliptin (EMEA/H/C/005741) CHMP Decision?; October 11-14 CHMP AgendaPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other Oct 07 | 2021New NovoPen 6 Connected Pen Trial in T1DM (CONNECT 1); Lilly-sponsored Treprostinil/Sodium Citrate Infusion Site Pain Trial in T1DM; Dario Partners with New Employer Group; Ascensia Launches "This is Diabetes" CompetitionPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucagon, Glucose Monitoring, Other Oct 06 | 2021Medtronic Expands 630G/670G Pump Recall; Xeris Completes Acquisition of Strongbridge; DreaMed FDA Clearance for AI-based Clinical Decision Support System for T2DM; Know Labs Bio-RFID Readings Comparable to FDA-Cleared DevicesPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other, SGLT2i Oct 04 | 2021BI/Lilly Launch Educational CVRM Game for HCPs; MannKind INHALE-1 Pediatric Study Enrolls First Patient; Dietitian-based Resource with PWD LaunchedPurchase Blast
$599
Posted in: Other Oct 01 | 2021New T2DM Reversal Program Launched; Positive Interim Data from Ph1b/2a T1DM Study; EASD 2021 Key Press Releases (Oct 1)Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Sep 30 | 2021Lilly Presents SURPASS-3 CGM and MRI Sub-studies; Insulet Omnipod 5 Extension Study Results; Onduo Collaborates with Fitbit; EASD 2021 Key Press Releases (Sept 30)Purchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Other Sep 29 | 2021Nemaura Launches New Metabolic Health Program; Biocon Receives More Form 483 Observations; Virta Health Key Leadership Appointments; Dexcom G6 Coverage in Manitoba; EASD 2021 Key Press Releases (Sept 29)Purchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Glucose Monitoring Sep 28 | 2021Lilly Cuts Non-branded Lispro Prices By 40%; Positive Ph1 Data for New GLP-1RA Asset; Lifescan Presents Tu Salud Trial Data in Hispanic Population; EASD 2021 Key Press Releases (Sept 28)Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Sep 27 | 2021Biocorp and Novo Mallya Partnership; Nemaura Signs Contract for Non-invasive CGM EU Distribution; AHA Late-breaking Science Sessions Released; EASD 2021 Key Press Releases (Sept 27)Purchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Sep 23 | 2021New Non-invasive BGM; Amarin Updates Vascepa US Go-to-market Strategy; Welldoc Receives 510(k) Clearance for Bolus and Premixed Insulin Titration; CinFina Agreement with Janssen for QW Obesity AssetsPurchase Blast
$599
Posted in: Other Sep 20 | 2021Kerendia Trial Initiated in Non-T2DM CKD Patients (FIND-CKD); New Virtual Diabetes Platform LaunchedPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Sep 17 | 2021Diamyd's Ph3 T1DM Vaccine Placed on Partial Clinical Hold; Osama Hamdy Joins Nemaura Scientific Board; Medtronic Licenses Implantable Pump; Diabeloop joins the AACE Corporate Advisory Program and Appoints US Scientific AdvisorsPurchase Blast
$599
Posted in: Basal Insulin, GLP-1RA, Other Sep 15 | 2021Novo Nordisk Center for Genomic Mechanisms of Disease Launched; Lifescan and Welldoc Partnership; Xeris Approved to Acquire StrongBridge Pharma; Oramed Reaches 50% Enrollment in NASHPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Other, SGLT2i Sep 13 | 2021September 13-16 CHMP Agenda; Dexcom Exec Joins iRhythm as CEO; Provention Teplizumab UpdatePurchase Blast
$599
Posted in: Other Sep 10 | 2021Another Inclisiran CVOT (VICTORION-2P); Not Even in Primary PreventionPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
